HASBROUCK HEIGHTS, N.J.--(BUSINESS WIRE)--July 10, 2006--Two independent analyst reports have “buy” recommendations for Nymox Pharmaceutical Corporation (NASDAQ: NYMX - News). These include: Dutton Associates (written by Dr. William Prather on June 6, 2006) and Cohen Independent Research Group (written on May 5, 2006).
